FY2029 Earnings Forecast for VRDN Issued By Leerink Partnrs
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Leerink Partnrs decreased their FY2029 earnings per share (EPS) estimates for Viridian Therapeutics in a report released on Thursday, February 27th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn $2.85 per share for the year, down from their previous forecast of $3.00. The […]
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Leerink Partnrs decreased their FY2029 earnings per share (EPS) estimates for Viridian Therapeutics in a report released on Thursday, February 27th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn $2.85 per share for the year, down from their previous forecast of $3.00. The […]
